Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Share News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 696.00
Bid: 700.00
Ask: 703.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.429%)
Open: 699.00
High: 704.00
Low: 689.00
Prev. Close: 696.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Bodycote outlook confident despite swing to loss in 2020

Fri, 12th Mar 2021 08:32

(Alliance News) - Bodycote PLC on Friday said it swung to loss in 2020 but said it is set to take advantage of an upturn in activity going forward as the economy reopens.

Bodycote highlighted that the fall in demand that occurred in the second quarter led to a drop in revenue that was "significantly greater than even the worst points of the global financial crisis in 2008 and 2009".

The Macclesfield, England-based pressing and coatings services provider reported a revenue decline of 17% in 2020 to GBP598.0 million. It swung to a pretax loss of GBP1.5 million from GBP123.9 million profit recorded in 2019.

Bodycote declared a dividend of 19.4 pence, slightly higher than 19.3p paid the year before.

"This continues Bodycote's uninterrupted 30-year track record of growing or maintaining the dividend and reflects the board's confidence in the group's future earnings and cash flow potential," said Chief Executive Stephen Harris.

"The board is confident that Bodycote is well-placed to drive growth and take advantage of the upturn in activity across all of its markets as they strengthen," added Harris.

FTSE 250-listed Bodycote shares were trading 1.4% lower in London on Friday at 791.00p each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Mar 2021 07:36

Bodycote revenues, profits fall as it repositions business

(Sharecast News) - Bodycote's revenues fell 16.9% in 2020 to £598m, it said on Friday, as its organic revenues declined 20%.

Read more
5 Mar 2021 15:56

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Feb 2021 13:46

Tuesday broker round-up

(Sharecast News) - Spirent Communications: Canaccord upgrades to buy with a target price of 275p.

Read more
9 Feb 2021 09:31

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

Read more
5 Feb 2021 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
20 Jan 2021 09:40

LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood

LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood

Read more
18 Jan 2021 09:34

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

Read more
15 Jan 2021 09:38

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

Read more
31 Dec 2020 17:12

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
9 Dec 2020 09:50

UK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group

UK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group

Read more
3 Dec 2020 09:34

UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform

UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform

Read more
30 Nov 2020 13:40

Monday broker round-up

(Sharecast News) - Bodycote: JP Morgan downgrades to underweight with a target price of 635p.

Read more
30 Nov 2020 09:49

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

Read more
30 Nov 2020 08:25

JPMorgan downgrades Bodycote, cites near-term pressures

(Sharecast News) - JPMorgan Cazenove downgraded heat treatments supplier Bodycote on Monday to 'underweight' from 'neutral' and cut the price target 635p from 670p as it argued that near-term pressures will weigh on the stock.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.